Indeed RECQ1 expression correlated with cisplatin resistance in oral squamous cell carcinoma (Zhang et al., 2006) and the depletion of RECQ1 significantly augmented the in vivo anticancer effects of the drug cis-platinum (II) diammine dichloride (Arai et al., 2011). The gene discussed is RECQL; the disease is oral cavity squamous cell carcinoma.